NHS: Diabetes
Debate between Lord Morris of Aberavon and Earl of Courtown
Lord Morris of Aberavon
To ask Her Majesty’s Government what steps they are taking to ensure that the National Health Service receives adequate funding to provide treatment to those with type 2 diabetes and to manage their increased risk of developing cancer.
The Earl of Courtown (Con)
My Lords, it is for local organisations to commission services to meet the healthcare needs of their populations, taking account of local and national priorities, including for diabetes and cancer. Funding has been made available through to 2020-21, and we expect it to be spent in line with the priorities set out in NHS England’s mandate, including for diabetes.
Lord Morris of Aberavon (Lab)
My Lords, I repeat my previous declaration of interest. Since diabetes has doubled in 20 years, making it the fastest growing modern health crisis, should not one Minister be put in charge and report annually to Parliament, coupled with a new fund to support greater adoption of new technologies? The Prime Minister proudly wore her flash monitoring device at the Mansion House; regrettably, the device is available on the NHS in only 63% of areas—others have to pay about £100 a month for the device. The hold-up of universal access is not with the clinicians but with the clinical commissioning groups. Will the Secretary of State take a personal interest in the development of this problem?
The Earl of Courtown
I thank the noble and learned Lord for that question. In particular he raised the issue of flash monitoring units. As the noble and learned Lord is aware, they are a very useful tool in the management and control of the problems people have with diabetes. Many CCGs perform very well, but some do not provide this service. They are being encouraged to do so.